Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Abstract on Ph2 study of Varlitinib gets acceptance for oral prentation at CSCP 2019

biospectrumasiaAugust 28, 2019

Tag: Ph2 study , oral prentation , CSCP 2019

PharmaSources Customer Service